Generate Biomedicines: Funding, Investors & Team (Sep 2026)
Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines. It pioneers in the field of Generative Biology, a revolutionary approach to drug development that allows them to program protein-based modalities for the first time. Generate Biomedicines has proved that its machine-learning platform can generate new biological molecules with therapeutic value, accelerating the drug discovery process.
Generate Biomedicines has raised $370M across 2 funding rounds on record, the most recent an undisclosed round announced in Dec 2024.
Generate Biomedicines Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Generate Biomedicines Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Generate Biomedicines raised $370M in a Series B announced in Nov 2021.
3.1 years later, an undisclosed round was announced in Dec 2024 with no disclosed amount.
Generate Biomedicines Founders and Leadership Team
Contact details for the Generate Biomedicines team: 1 of 2 have an email address on file.
Start 14-day free trial →Generate Biomedicines Funding Compared to Other Biotechnology Startups
Funded Startups Like Generate Biomedicines in Biotechnology and Somerville
Companies Similar to Generate Biomedicines
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Generate Biomedicines Funding FAQs
What does Generate Biomedicines do?
Generate Biomedicines is a biotechnological company focusing on creating breakthrough medicines. It pioneers in the field of Generative Biology, a revolutionary approach to drug development that allows them to program protein-based modalities for the first time. Generate Biomedicines has proved that its machine-learning platform can generate new biological molecules with therapeutic value, accelerating the drug discovery process.
How much funding has Generate Biomedicines raised?
Generate Biomedicines has raised $370M across 2 rounds on record.
When did Generate Biomedicines last raise funding?
Generate Biomedicines' most recent funding round on record was announced in Dec 2024. The amount was not disclosed.
Who founded Generate Biomedicines?
FundedIQ lists Gevorg Grigoryan (Founder) at Generate Biomedicines.
Who is the CEO of Generate Biomedicines?
Michael Nally is listed as CEO at Generate Biomedicines.
Where is Generate Biomedicines headquartered?
Generate Biomedicines is based in Somerville, Massachusetts, United States.
How many employees does Generate Biomedicines have?
Generate Biomedicines is in the 251-500 employee band.
About FundedIQ's Generate Biomedicines Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Generate Biomedicines is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.